Citation 86414

KIM,GS: SEONG,JD: PARK,SY: OH,SR: KWACK,YH:. (2000). STEROIDAL SAPONINS FROM THE RHIZOMES OF ASPARAGUS OLIGOCLONOS AND THEIR ANTIBACTERIAL ACTIVITY.. 43(2)

Citation Details

Title	STEROIDAL SAPONINS FROM THE RHIZOMES OF ASPARAGUS OLIGOCLONOS AND THEIR ANTIBACTERIAL ACTIVITY.
Authors	KIM,GS: SEONG,JD: PARK,SY: OH,SR: KWACK,YH:
Year	2000
Volume	43
Issue	2

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Asparagus oligoclonus (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
18	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	None
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
30	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	INACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-3-BETA-OL,25(S): 3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[BETA-D-XYLOPYRANOSYL(1-4)]-BETA-D-GLUCOPYRANOSYL]:	EQUIVOCAL

Citation 86414

Citation Details

Summary

Organisms and Their Experiments (1)

Asparagus oligoclonus (LILIACEAE)

Show SPARQL Queries (1)

Query 1